Alumis
Price & Volume
Stats
See moreOpen | $27.74 |
Previous Close | $28.14 |
Day Range | $26.86-$28.12 |
52W Range | $3-$30.60 |
Market Cap | $3.4B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $8.4M |
Revenue Growth (YoY) | -90% |
Gross Profit (12 Mos) | $8.4M |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • last month
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
Yahoo Finance • last month
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
Yahoo Finance • 3 months ago
Commit To Buy Alumis At $15, Earn 34.6% Annualized Using Options
Yahoo Finance • 3 months ago
Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says
About
CEO | Mr. Martin Babler Ph.D. |
Address | 280 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 225 |